Abstract 97P
Background
The search for genetic markers of prognosis seems promising for individualization of treatment programs for patients with brain tumors. The aim of our study is to study the dynamics of the concentration of mutant DNA in the BRAF gene in peripheral blood plasma during and after radiation therapy and compare these data with the effect of treatment.
Methods
Digital droplet PCR (ddPCR) was used to determine the concentration of mutant tumor DNA in 209 blood plasma samples (groups included 57 patients with pons tumors and 29 patients with glioma of the other localization). The samples were obtained before the course of RT, during RT (5-8 fraction) and after RT (27-30 fraction). According to the results of radiation therapy, patients were divided into two groups: 1 – the onset of tumor recurrence less than 6 months after the end of the course of RT; 2 – stabilization of the process for 6 months or more after the end of the course of RT.
Results
A significant increase in the relative concentration of mutant (V600E) DNA of the BRAF gene in peripheral blood at the beginning of the RT course and its decrease by the end of the course in the relapse-free group was shown. No changes or an increase in BRAFV600E levels by the end of the RT course was typical for patients with relapse in the early stages.
Conclusions
Methods of liquid biopsy allow to estimate changes in the amount of mutant (tumor) DNA in peripheral blood plasma in children with brain glioma in RT. Increase in the level of mutant DNA correlates with a more stable effect of the treatment.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology (RSCRR) of the Ministry of Healthcare of the Russian Federation (Russian Scientific Center of Roentgenoradiology).
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
20P - Effects of <italic>Apis dorsata</italic> honey on the expression of selected CYP450, pro-apoptotic, and anti-apoptotic genes during induced cytotoxicity in cyclophosphamide-treated human lung carcinoma (A549) cells
Presenter: Jose Kenneth Narag
Session: Cocktail & Poster Display session
Resources:
Abstract
21P - Hsa_circ_0009061 inhibits the progression of bladder cancer through the miR-889-3p/CPEB3 axis
Presenter: Minkang Wu
Session: Cocktail & Poster Display session
Resources:
Abstract
22P - Exploring exportin-1 as a therapeutic vulnerability in lung squamous cell carcinoma
Presenter: Vidushi Durani
Session: Cocktail & Poster Display session
Resources:
Abstract
23P - Identification of HPSE as potential novel therapeutic target for lung adenocarcinoma patients
Presenter: Samuel Doré
Session: Cocktail & Poster Display session
Resources:
Abstract
24P - High-throughput plasma proteomics profiling in early breast cancer
Presenter: Isabella Lombardo
Session: Cocktail & Poster Display session
Resources:
Abstract
25P - Immunohistochemical analysis of ROR1 and BMI-1 expression in luminal breast cancer
Presenter: Sergey Vtorushin
Session: Cocktail & Poster Display session
Resources:
Abstract
26P - Associations between cancer stem cells (CSC) markers and androgen (AR) and estrogen (ER) receptors expression in prostate cancer (PCa)
Presenter: Marina Puchinskaya
Session: Cocktail & Poster Display session
Resources:
Abstract
27P - Proteomic profiling reveals organ-specific differences in metastases and identifies potential biomarkers for recurrence risk in localized colon cancer
Presenter: Blanca García-Micó
Session: Cocktail & Poster Display session
Resources:
Abstract
28P - Collagen-activated signalling pathway is significantly hypermethylated in high-grade serous ovarian cancer (HGSOC) patients treated with platinum-containing neoadjuvant chemotherapy (NACT)
Presenter: Jose Alejandro Perez Fidalgo
Session: Cocktail & Poster Display session
Resources:
Abstract
29P - Quantitative tissue analysis reveal adenylate kinase 2 protein signatures: Therapeutic target for meningioma
Presenter: Rashmi Rana
Session: Cocktail & Poster Display session
Resources:
Abstract